Epithelial-mesenchymal transitions: From cell plasticity to concept elasticity

Current Topics in Developmental Biology

Volumn 112, Issue , 2015, Pages 273-300

  Savagner, Pierre ^a  

^a INSERM   (France)

Author keywords

Cadherin; Carcinoma; Epithelial mesenchymal transition; Gastrulation; Metastable phenotype; Migration; Morphogenesis; Neural crest cells

Indexed keywords

ANIMAL; CELL ADHESION; CELL MOTION; CELL PLASTICITY; DISEASE COURSE; ELASTICITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NEOPLASMS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL PLASTICITY; DISEASE PROGRESSION; ELASTICITY; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84926135569     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ctdb.2014.11.021     Document Type: Chapter

References (152)

1. Abell A.N., Jordan N.V., Huang W., Prat A., Midland A.A., Johnson N.L., et al. MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell 2011, 8(5):525-537.
2. Aceto N., Bardia A., Miyamoto D.T., Donaldson M.C., Wittner B.S., Spencer J.A., et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014, 158(5):1110-1122.
3. Akalay I., Janji B., Hasmim M., Noman M.Z., Andre F., De Cremoux P., et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Research 2013, 73(8):2418-2427.
4. Arnoux V., Come C., Kusewitt D., Savagner P. Cutaneous wound healing: A partial and reversible EMT. Rise and fall of epithelial phenotype: Concepts of epithelial-mesenchymal transition 2005, 111-134. Landes Biosciences, Austin, TX. P. Savagner (Ed.).
5. Aybar M.J., Mayor R. Early induction of neural crest cells: Lessons learned from frog, fish and chick. Current Opinion in Genetics & Development 2002, 12(4):452-458.
6. Barnes R.M., Firulli A.B. A twist of insight-The role of Twist-family bHLH factors in development. International Journal of Developmental Biology 2009, 53(7):909-924.
7. Bates R.C., Mercurio A.M. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biology & Therapy 2005, 4(4):365-370.
8. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biology 2000, 2(2):84-89.
9. Becker K.F., Rosivatz E., Blechschmidt K., Kremmer E., Sarbia M., Hofler H. Analysis of the E-cadherin repressor Snail in primary human cancers. Cells, Tissues, Organs 2007, 185(1-3):204-212.
10. Bennett G.S. Changes in intermediate filament composition during neurogenesis. Current Topics in Developmental Biology 1987, 21:151-183.
11. Berx G., Cleton-Jansen A.M., Nollet F., de Leeuw W.J., van de Vijver M., Cornelisse C., et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO Journal 1995, 14(24):6107-6115.
12. Biamonti G., Bonomi S., Gallo S., Ghigna C. Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). Cellular and Molecular Life Sciences 2012, 69(15):2515-2526.
13. Birchmeier W. E-cadherin as a tumor (invasion) suppressor gene. Bioessays 1995, 17(2):97-99.
14. Boyer B., Tucker G.C., Valles A.M., Franke W.W., Thiery J.P. Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. Journal of Cell Biology 1989, 109(4Pt. 1):1495-1509.
15. Brabletz T. To differentiate or not-Routes towards metastasis. Nature Reviews Cancer 2012, 12(6):425-436.
16. Brown R.L., Reinke L.M., Damerow M.S., Perez D., Chodosh L.A., Yang J., et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. Journal of Clinical Investigation 2011, 121(3):1064-1074.
17. Bryant J.L., Britson J., Balko J.M., Willian M., Timmons R., Frolov A., et al. A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. British Journal of Cancer 2012, 106(1):148-156.
18. Byers L.A., Diao L., Wang J., Saintigny P., Girard L., Peyton M., et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clinical Cancer Research 2013, 19(1):279-290.
19. Cakouros D., Raices R.M., Gronthos S., Glackin C.A. Twist-ing cell fate: Mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis. Journal of Cellular Biochemistry 2010, 110(6):1288-1298.
20. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biology 2000, 2(2):76-83.
21. Caramel J., Papadogeorgakis E., Hill L., Browne G.J., Richard G., Wierinckx A., et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 2013, 24(4):466-480.
22. Carver E.A., Jiang R., Lan Y., Oram K.F., Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Molecular and Cellular Biology 2001, 21(23):8184-8188.
23. Casas E., Kim J., Bendesky A., Ohno-Machado L., Wolfe C.J., Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Research 2011, 71(1):245-254.
24. Chang C.J., Chao C.H., Xia W., Yang J.Y., Xiong Y., Li C.W., et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology 2011, 13(3):317-323.
25. Chen X., Gumbiner B.M. Paraxial protocadherin mediates cell sorting and tissue morphogenesis by regulating C-cadherin adhesion activity. Journal of Cell Biology 2006, 174(2):301-313.
26. Cheng C.W., Wu P.E., Yu J.C., Huang C.S., Yue C.T., Wu C.W., et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001, 20(29):3814-3823.
27. Cho K.B., Cho M.K., Lee W.Y., Kang K.W. Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells. Cancer Letters 2010, 293(2):230-239.
28. Christofori G., Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends in Biochemical Sciences 1999, 24(2):73-76.
29. Chui M.H. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step. International Journal of Cancer 2013, 132(7):1487-1495.
30. Come C., Magnino F., Bibeau F., De Santa Barbara P., Becker K.F., Theillet C., et al. Snail and slug play distinct roles during breast carcinoma progression. Clinical Cancer Research 2006, 12(18):5395-5402.
31. Creighton C.J., Chang J.C., Rosen J.M. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. Journal of Mammary Gland Biology and Neoplasia 2010, 15(2):253-260.
32. Daniel C.W., Strickland P., Friedmann Y. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Developmental Biology 1995, 169(2):511-519.
33. Dave B., Mittal V., Tan N.M., Chang J.C. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Research 2012, 14(1):202.
34. De Craene B., Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews Cancer 2013, 13(2):97-110.
35. De Vries W.N., Evsikov A.V., Haac B.E., Fancher K.S., Holbrook A.E., Kemler R., et al. Maternal beta-catenin and E-cadherin in mouse development. Development 2004, 131(18):4435-4445.
36. Den Z., Cheng X., Merched-Sauvage M., Koch P.J. Desmocollin 3 is required for pre-implantation development of the mouse embryo. Journal of Cell Science 2006, 119(Pt. 3):482-489.
37. Derycke L.D., Bracke M.E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. International Journal of Developmental Biology 2004, 48(5-6):463-476.
38. Dhasarathy A., Phadke D., Mav D., Shah R.R., Wade P.A. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS One 2011, 6(10):e26514.
39. DiMeo T.A., Anderson K., Phadke P., Fan C., Perou C.M., Naber S., et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Research 2009, 69(13):5364-5373.
40. Dong C.Y., Liu X.Y., Wang N., Wang L.N., Yang B.X., Ren Q., et al. Twist-1, a novel regulator of hematopoietic stem cell self-renewal and myeloid lineage development. Stem Cells 2014, 32(12):3173-3182.
41. Dong C., Yuan T., Wu Y., Wang Y., Fan T.W., Miriyala S., et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 2013, 23(3):316-331.
42. Duband J.L., Dufour S., Hatta K., Takeichi M., Edelman G.M., Thiery J.P. Adhesion molecules during somitogenesis in the avian embryo. Journal of Cell Biology 1987, 104(5):1361-1374.
43. Duband J.L., Thiery J.P. Distribution of fibronectin in the early phase of avian cephalic neural crest cell migration. Developmental Biology 1982, 93(2):308-323.
44. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., et al. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474(7350):179-183.
45. Ewald A.J., Huebner R.J., Palsdottir H., Lee J.K., Perez M.J., Jorgens D.M., et al. Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium. Journal of Cell Science 2012, 125(Pt. 11):2638-2654.
46. Fang X., Cai Y., Liu J., Wang Z., Wu Q., Zhang Z., et al. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 2011, 30(47):4707-4720.
47. Friedl P., Wolf K. Plasticity of cell migration: A multiscale tuning model. Journal of Cell Biology 2010, 188(1):11-19.
48. Frisch S.M. The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 1997, 19:705-709.
49. Frisch S.M., Schaller M., Cieply B. Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. Journal of Cell Science 2013, 126(Pt. 1):21-29.
50. Fu N., Lindeman G.J., Visvader J.E. The mammary stem cell hierarchy. Current Topics in Developmental Biology 2014, 107:133-160.
51. Fuxe J., Karlsson M.C. TGF-beta-induced epithelial-mesenchymal transition: A link between cancer and inflammation. Seminars in Cancer Biology 2012, 22(5-6):455-461.
52. Gao D., Vahdat L.T., Wong S., Chang J.C., Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Research 2012, 72(19):4883-4889.
53. Geradts J., de Herreros A.G., Su Z., Burchette J., Broadwater G., Bachelder R.E. Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas. Human Pathology 2011, 42(8):1125-1131.
54. Giampieri S., Manning C., Hooper S., Jones L., Hill C.S., Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nature Cell Biology 2009, 11(11):1287-1296.
55. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: A bidirectional interplay affecting tumor malignancy. Antioxidants & Redox Signaling 2012, 16(11):1248-1263.
56. Godde N.J., Galea R.C., Elsum I.A., Humbert P.O. Cell polarity in motion: Redefining mammary tissue organization through EMT and cell polarity transitions. Journal of Mammary Gland Biology and Neoplasia 2010, 15(2):149-168.
57. Goossens S., Janzen V., Bartunkova S., Yokomizo T., Drogat B., Crisan M., et al. The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization. Blood 2011, 117(21):5620-5630.
58. Greenburg G., Hay E.D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. Journal of Cell Biology 1982, 95(1):333-339.
59. Guo W., Keckesova Z., Donaher J.L., Shibue T., Tischler V., Reinhardt F., et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012, 148(5):1015-1028.
60. Hammerschmidt M., Wedlich D. Regulated adhesion as a driving force of gastrulation movements. Development 2008, 135(22):3625-3641.
61. Hatta K., Takeichi M. Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 1986, 320(6061):447-449.
62. Hay E.D. Organization and fine structure of epithelium and mesenchyme in the developing chick embryo 1968, Williams and Wilkins, Baltimore. R. Fleischmajer, R.E. Billingham (Eds.).
63. Heisenberg C.P., Solnica-Krezel L. Back and forth between cell fate specification and movement during vertebrate gastrulation. Current Opinion in Genetics & Development 2008, 18(4):311-316.
64. Hollestelle A., Peeters J.K., Smid M., Timmermans M., Verhoog L.C., Westenend P.J., et al. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer. Breast Cancer Research and Treatment 2013, 138(1):47-57.
65. Hotz B., Visekruna A., Buhr H.J., Hotz H.G. Beyond epithelial to mesenchymal transition: A novel role for the transcription factor Snail in inflammation and wound healing. Journal of Gastrointestinal Surgery 2010, 14(2):388-397.
66. Jiang Z., Jones R., Liu J.C., Deng T., Robinson T., Chung P.E., et al. RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle 2011, 10(10):1563-1570.
67. Jiang J., Tang Y.L., Liang X.H. EMT: A new vision of hypoxia promoting cancer progression. Cancer Biology & Therapy 2011, 11(8):714-723.
68. Katz E., Dubois-Marshall S., Sims A.H., Gautier P., Caldwell H., Meehan R.R., et al. An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. PLoS One 2011, 6(2):e17083.
69. Keller R. Cell migration during gastrulation. Current Opinion in Cell Biology 2005, 17(5):533-541.
70. Kerosuo L., Bronner-Fraser M. What is bad in cancer is good in the embryo: Importance of EMT in neural crest development. Seminars in Cell & Developmental Biology 2012, 23(3):320-332.
71. Kim S.H., Yamamoto A., Bouwmeester T., Agius E., Robertis E.M. The role of paraxial protocadherin in selective adhesion and cell movements of the mesoderm during Xenopus gastrulation. Development 1998, 125(23):4681-4690.
72. Kitten G.T., Markwald R.R., Bolender D.L. Distribution of basement membrane antigens in cryopreserved early embryonic hearts. Anatomical Record 1987, 217(4):379-390.
73. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: A cancer researcher's conceptual friend and foe. American Journal of Pathology 2009, 174(5):1588-1593.
74. Kurrey N.K., Jalgaonkar S.P., Joglekar A.V., Ghanate A.D., Chaskar P.D., Doiphode R.Y., et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009, 27(9):2059-2068.
75. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology 2014, 15(3):178-196.
76. Le Douarin N.M., Creuzet S., Couly G., Dupin E. Neural crest cell plasticity and its limits. Development 2004, 131:4637-4650.
77. Ledford H. Cancer theory faces doubts. Nature 2011, 472(7343):273.
78. Leopold P.L., Vincent J., Wang H. A comparison of epithelial-to-mesenchymal transition and re-epithelialization. Seminars in Cancer Biology 2012, 22(5-6):471-483.
79. Leptin M. Gastrulation movements: The logic and the nuts and bolts. Developmental Cell 2005, 8(3):305-320.
80. Levayer R., Lecuit T. Breaking down EMT. Nature Cell Biology 2008, 10(7):757-759.
81. Lim J., Thiery J.P. Epithelial-mesenchymal transitions: Insights from development. Development 2012, 139(19):3471-3486.
82. Lin C.C., Cheng T.L., Tsai W.H., Tsai H.J., Hu K.H., Chang H.C., et al. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Science Reports 2012, 2:785.
83. Loboda A., Nebozhyn M.V., Watters J.W., Buser C.A., Shaw P.M., Huang P.S., et al. EMT is the dominant program in human colon cancer. BMC Medical Genomics 2011, 4:9.
84. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133(4):704-715.
85. Mareel M., Bracke M., Van Roy F. Invasion promoter versus invasion suppressor molecules: The paradigm of E-cadherin. Molecular Biology Reports 1994, 19(1):45-67.
86. Marsden M., DeSimone D.W. Integrin-ECM interactions regulate cadherin-dependent cell adhesion and are required for convergent extension in Xenopus. Current Biology 2003, 13(14):1182-1191.
87. Michael M., Yap A.S. The regulation and functional impact of actin assembly at cadherin cell-cell adhesions. Seminars in Cell & Developmental Biology 2013, 24(4):298-307.
88. Moinfar F., Man Y.G., Arnould L., Bratthauer G.L., Ratschek M., Tavassoli F.A. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Research 2000, 60(9):2562-2566.
89. Monsonego-Ornan E., Kosonovsky J., Bar A., Roth L., Fraggi-Rankis V., Simsa S., et al. Matrix metalloproteinase 9/gelatinase B is required for neural crest cell migration. Developmental Biology 2012, 364(2):162-177.
90. Montero J.A., Carvalho L., Wilsch-Brauninger M., Kilian B., Mustafa C., Heisenberg C.P. Shield formation at the onset of zebrafish gastrulation. Development 2005, 132(6):1187-1198.
91. Moody S.E., Perez D., Pan T.C., Sarkisian C.J., Portocarrero C.P., Sterner C.J., et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005, 8(3):197-209.
92. Morali O.G., Savagner P., Larue L. Epithelium mesenchyme transitions are crucial morphogenetic events occurring during early development. Rise and fall of epithelial phenotype: Concepts of epithelial-mesenchymal transition 2005, Landes Bioscience; Kluwer Academic, Georgetown, TX; New York, NY. P. Savagner (Ed.).
93. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3(8):e2888.
94. Murray S.A., Oram K.F., Gridley T. Multiple functions of Snail family genes during palate development in mice. Development 2007, 134(9):1789-1797.
95. Nabeshima K., Inoue T., Shimao Y., Okada Y., Itoh Y., Seiki M., et al. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Research 2000, 60(13):3364-3369.
96. Nakagawa S., Takeichi M. Neural crest emigration from the neural tube depends on regulated cadherin expression. Development 1998, 125(15):2963-2971.
97. Nakaya Y., Sheng G. Epithelial to mesenchymal transition during gastrulation: An embryological view. Development, Growth & Differentiation 2008, 50(9):755-766.
98. Nakaya Y., Sheng G. EMT in developmental morphogenesis. Cancer Letters 2013, 341(1):9-15.
99. Nassour M., Idoux-Gillet Y., Selmi A., Come C., Faraldo M.L., Deugnier M.A., et al. Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis. PLoS One 2012, 7(12):e53498.
100. Nieman M.T., Prudoff R.S., Johnson K.R., Wheelock M.J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. Journal of Cell Biology 1999, 147(3):631-644.
101. Nieto M.A., Cano A. The epithelial-mesenchymal transition under control: Global programs to regulate epithelial plasticity. Seminars in Cancer Biology 2012, 22(5-6):361-368.
102. Nieto M.A., Sargent M.G., Wilkinson D.G., Cooke J. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994, 264(5160):835-839.
103. Nowotschin S., Hadjantonakis A.K. Cellular dynamics in the early mouse embryo: From axis formation to gastrulation. Current Opinion in Genetics & Development 2010, 20(4):420-427.
104. Ormerod E.J., Rudland P.S. Regeneration of mammary glands in vivo from isolated mammary ducts. Journal of Embryology and Experimental Morphology 1986, 96:229-243.
105. Page M. Changing patterns of cytokeratins and vimentin in the early chick embryo. Development 1989, 105(1):97-107.
106. Peinado H., Iglesias-de Del Carmen, la Cruz M., Olmeda D., Csiszar K., Fong K.S., et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO Journal 2005, 24(19):3446-3458.
107. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. International Review of Cytology 2005, 243:287-335.
108. Proia T.A., Keller P.J., Gupta P.B., Klebba I., Jones A.D., Sedic M., et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 2011, 8(2):149-163.
109. Rakha E.A., Teoh T.K., Lee A.H., Nolan C.C., Ellis I.O., Green A.R. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: An immunohistochemical study. Histopathology 2013, 62(5):695-701.
110. Reima I., Lehtonen E., Virtanen I., Flechon J.E. The cytoskeleton and associated proteins during cleavage, compaction and blastocyst differentiation in the pig. Differentiation 1993, 54(1):35-45.
111. Ribeiro A.S., Sousa B., Carreto L., Mendes N., Nobre A.R., Ricardo S., et al. P-cadherin functional role is dependent on E-cadherin cellular context: A proof of concept using the breast cancer model. Journal of Pathology 2013, 229(5):705-718.
112. Roxanis I. Occurrence and significance of epithelial-mesenchymal transition in breast cancer. Journal of Clinical Pathology 2013, 66(6):517-521.
113. Savagner P. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001, 23(10):912-923.
114. Savagner P., Yamada K.M., Thiery J.P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. Journal of Cell Biology 1997, 137(6):1403-1419.
115. Scheel C., Weinberg R.A. Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Seminars in Cancer Biology 2012, 22(5-6):396-403.
116. Seki K., Fujimori T., Savagner P., Hata A., Aikawa T., Ogata N., et al. Mouse Snail-related transcription repressors regulate chondrocyte extracellular matrix, type II collagen and aggrecan. Journal of Biological Chemistry 2002, 278:41862-41870.
117. Semb H., Christofori G. The tumor-suppressor function of E-cadherin. American Journal of Human Genetics 1998, 63(6):1588-1593.
118. Shamir E.R., Pappalardo E., Jorgens D.M., Coutinho K., Tsai W.T., Aziz K., et al. Twist1-induced dissemination preserves epithelial identity and requires E-cadherin. Journal of Cell Biology 2014, 204(5):839-856.
119. Shapiro I.M., Cheng A.W., Flytzanis N.C., Balsamo M., Condeelis J.S., Oktay M.H., et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genetics 2011, 7(8):e1002218.
120. Shi J., Severson C., Yang J., Wedlich D., Klymkowsky M.W. Snail2 controls mesodermal BMP/Wnt induction of neural crest. Development 2011, 138(15):3135-3145.
121. Soini Y., Tuhkanen H., Sironen R., Virtanen I., Kataja V., Auvinen P., et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer 2011, 11:73.
122. Solnica-Krezel L. Conserved patterns of cell movements during vertebrate gastrulation. Current Biology 2005, 15(6):R213-R228.
123. Solnica-Krezel L., Sepich D.S. Gastrulation: Making and shaping germ layers. Annual Review of Cell and Developmental Biology 2012, 28:687-717.
124. Sternberg J., Kimber S.J. The relationship between emerging neural crest cells and basement membranes in the trunk of the mouse embryo: A TEM and immunocytochemical study. Journal of Embryology and Experimental Morphology 1986, 98:251-268.
125. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327(6119):239-242.
126. Sun Y., Shao L., Bai H., Wang Z.Z., Wu W.S. Slug deficiency enhances self-renewal of hematopoietic stem cells during hematopoietic regeneration. Blood 2010, 115(9):1709-1717.
127. Tan T.Z., Miow Q.H., Miki Y., Noda T., Mori S., Huang R.Y., et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Molecular Medicine 2014.
128. Taneyhill L.A., Schiffmacher A.T. Cadherin dynamics during neural crest cell ontogeny. Progress in Molecular Biology and Translational Science 2013, 116:291-315.
129. Tarin D., Thompson E.W., Newgreen D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research 2005, 65(14):5996-6000. discussion 6000-5991.
130. Theveneau E., Mayor R. Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Developmental Biology 2012, 366(1):34-54.
131. Thiery J.P. Metastasis: Alone or together?. Current Biology 2009, 19(24):R1121-R1123.
132. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139(5):871-890.
133. Tiwari N., Gheldof A., Tatari M., Christofori G. EMT as the ultimate survival mechanism of cancer cells. Seminars in Cancer Biology 2012, 22(3):194-207.
134. Tiwari N., Tiwari V.K., Waldmeier L., Balwierz P.J., Arnold P., Pachkov M., et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell 2013, 23(6):768-783.
135. Trimboli A.J., Fukino K., de Bruin A., Wei G., Shen L., Tanner S.M., et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Research 2008, 68(3):937-945.
136. Tsai J.H., Donaher J.L., Murphy D.A., Chau S., Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012, 22(6):725-736.
137. Tucker G.C., Boyer B., Valles A.M., Thiery J.P. Combined effects of extracellular matrix and growth factors on NBT-II rat bladder carcinoma cell dispersion. Journal of Cell Science 1991, 100(Pt. 2):371-380.
138. Valles A.M., Boyer B., Badet J., Tucker G.C., Barritault D., Thiery J.P. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(3):1124-1128.
139. Van de Putte T., Maruhashi M., Francis A., Nelles L., Kondoh H., Huylebroeck D., et al. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. American Journal of Human Genetics 2003, 72(2):465-470.
140. Vanharanta S., Massague J. Origins of metastatic traits. Cancer Cell 2013, 24(4):410-421.
141. Vannier C., Mock K., Brabletz T., Driever W. Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development. Journal of Biological Chemistry 2013, 288(26):18643-18659.
142. Voutsadakis I.A. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer. Tumour Biology 2012, 33(4):897-910.
143. Warzecha C.C., Carstens R.P. Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Seminars in Cancer Biology 2012, 22(5-6):417-427.
144. Weidner K.M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. Journal of Cell Biology 1990, 111(5Pt. 1):2097-2108.
145. Williams J.M., Daniel C.W. Mammary ductal elongation: Differentiation of myoepithelium and basal lamina during branching morphogenesis. Developmental Biology 1983, 97(2):274-290.
146. Wright J.A., Richer J.K., Goodall G.J. microRNAs and EMT in mammary cells and breast cancer. Journal of Mammary Gland Biology and Neoplasia 2010, 15(2):213-223.
147. Wu W.S., Heinrichs S., Xu D., Garrison S.P., Zambetti G.P., Adams J.M., et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005, 123(4):641-653.
148. Wu Z.Q., Li X.Y., Hu C.Y., Ford M., Kleer C.G., Weiss S.J. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(41):16654-16659.
149. Wu C.Y., Tsai Y.P., Wu M.Z., Teng S.C., Wu K.J. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends in Genetics 2012, 28(9):454-463.
150. Zhang C., Klymkowsky M.W. Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-kappaB via Nodal and Cerberus. Developmental Biology 2009, 331(2):340-349.
151. Zhang J., Ma L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Reviews 2012, 31(3-4):653-662.
152. Zheng H., Kang Y. Multilayer control of the EMT master regulators. Oncogene 2014, 33(14):1755-1763.